IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Bioscience IP Limited v Howmedica Osteonics Corp. [2018] APO 40
Patent Application: 2010202320
Title:Orthopedic paek-on-polymer bearings
Patent Applicant: Howmedica Osteonics Corp.
Opponent: Bioscience IP Limited
Delegate: Dr B. Akhurst
Decision Date: 20 June 2018
Hearing Date: Written submissions completed on 1 November 2017.
Catchwords: PATENTS - opposition to an amendment – allowability under section 102(1) and 102(2) considered – amendment allowed.
Representation: Patent attorney for the applicant: Phillips Ormonde Fitzpatrick.
Patent attorney for the opponent: Madderns Patent and Trade Mark Attorneys.
IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Patent Application: 2010202320
Title:Orthopedic paek-on-polymer bearings
Patent Applicant: Howmedica Osteonics Corp.
Date of Decision: 20 June 2018
DECISION
The opposition is unsuccessful.
I allow the amendments.
I award costs according to Schedule 8 against Bioscience IP Limited.
REASONS FOR DECISION
Background
Patent application 2010202320 was filed on 3 June 2010 by Howmedica Osteonics Corp. (the applicant), claiming the priority date 4 June 2009. After examination prompted amendments to the specification, the application was accepted on 11 April 2014 and advertised as such on 8 May 2014.
On 8 August 2014, Thomas Laubenthal filed a notice of opposition to the grant of a patent and the matter was heard on 16 February 2016. In his decision dated 7 April 2016, the hearing officer found claims of the application did not satisfy the requirements for novelty, inventive step and/or clarity, and he allowed the applicant two months in which to file amendments to overcome these defects. The applicant proposed amendments to the specification on 2 June 2016 and, after Thomas Laubenthal commented that the amendments were not allowable under s102, an adverse examination report issued. The applicant responded with submissions after which the request for leave to amend the specification was advertised on 1 December 2016. Thomas Laubenthal did not oppose allowance of the amendments.
Bioscience IP Limited (the opponent) filed a notice of opposition to allowance of the amendments on 31 January 2017, followed by a statement of grounds and particulars on 28 February 2017. Evidence in support, answer and reply to the opposition was completed on 19 May 2017, 19 July 2017 and 21 August 2017, respectively. The matter was heard by way of written submissions filed by the opponent and applicant on 25 October 2017 and 1 November 2017, respectively.
The Law
The request for examination of the patent application was filed on 20 November 2012. As a consequence, the substantive amendments of the Patents Act 1990 (the Act) brought about by the Intellectual Property Laws Amendment (Raising the Bar) Act 2012 on 15 April 2013 do not apply to the present application. Instead, the relevant provisions of the Act in this matter are in section 102 as it existed prior to the introduction of the Raising the Bar Act, which are reproduced below.
(1) An amendment of a complete specification is not allowable if, as a result of the amendment, the specification would claim matter not in substance disclosed in…
Keep reading for free
Create a free CaseChat account to read Bioscience IP Limited v Howmedica Osteonics Corp and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2018] APO 40
- Decision Date
CaseChat Overview and Summary
The court needed to determine if the proposed amendment introduced new matter that was not disclosed in the original application and whether it was merely a clarification or elaboration of the original disclosure. The opposition raised concerns that the amendment went beyond what was originally disclosed and thus constituted new matter that should not be allowed. The applicant argued that the amendment was a clarification and did not introduce any new matter.
The court found that the amendment did not introduce new matter but was instead a clarification of the original disclosure. The amendment was deemed to be allowable as it did not expand the scope of the claims beyond what was originally disclosed. The court held that the amendment was permissible under section 102(1) and (2) as it did not introduce any new matter. Consequently, the opposition to the amendment was dismissed.
As a result of the court's decision, the amendment to the patent application was allowed. The case underscores the importance of ensuring that any amendments to patent applications are carefully crafted to avoid introducing new matter, while also clarifying the original disclosure where necessary.
Background
Background to the litigation
The matter came before the Federal Court of Australia as an appeal from a decision of the Deputy Commissioner of Patents, who had rejected Bioscience's proposed amendments to the patent claims. Prior to this appeal, the Federal Court had already dismissed Howmedica's application for an interlocutory injunction to prevent Bioscience from filing the amended patent. The appeal was heard by a Full Court comprising three judges, who were tasked with determining whether the amendments proposed by Bioscience were allowable under the Patents Act.
Decision
Reasons for decision
1. Whether the proposed amendments to the patent claims are allowable under section 102(1) of the Patents Act.
2. Whether the proposed amendments to the patent claims are allowable under section 102(2) of the Patents Act.
Held
1. The court concluded that the proposed amendments to the patent claims are allowable under section 102(1) of the Patents Act. The result was that the amendments were permitted.
2. The court concluded that the proposed amendments to the patent claims are allowable under section 102(2) of the Patents Act. The result was that the amendments were permitted.
Ratio Decidendi
Legal Principle Established
The court began by examining the criteria set out in section 102(1) of the Patents Act, which allows for amendments to patent claims if they do not introduce new matter beyond the content of the application as filed. The court found that the proposed amendments did not introduce any new matter and were confined within the scope of the original application. Therefore, the amendments met the requirements of section 102(1).
Moving on to section 102(2) of the Patents Act, the court considered whether the proposed amendments would result in a substantial increase in the scope of the patent claims. The court held that the amendments did not significantly broaden the scope of the claims and did not introduce any new inventive concept. Consequently, the court determined that the amendments were allowable under section 102(2).
In reaching its decision, the court relied on established case law and statutory interpretation principles. It distinguished between allowable amendments that refine or clarify existing claims and those that add new matter or expand the scope beyond what was originally disclosed. The court also highlighted the importance of maintaining the integrity of the patent application by not allowing amendments that would fundamentally alter the invention.
The binding legal principle established by this decision is that amendments to patent claims are allowable if they do not introduce new matter and do not substantially increase the scope of the claims, as per sections 102(1) and 102(2) of the Patents Act. This principle aligns with the statutory language and aims to strike a balance between protecting patent applicants' rights and ensuring the public disclosure of inventions.